Financials
- Market Capitalization 15.6 B
- Employee 2 500
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
24.68
売上高対価格比率
5.15
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 479 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.00 USD | -0.22% | -1.32% | +4.71% | +26.89% | 28.04 B USD | ||
| 619 | VTRS Viatris Inc. - Common Stock | 16.43 USD | +0.55% | -0.24% | -7.07% | +58.74% | 18.87 B USD | ||
| 822 | ELAN Elanco Animal Health Incorporated Common Stock | 23.77 USD | -1.45% | -1.94% | -9.96% | +6.14% | 11.88 B USD | ||
| 904 | RDY Dr. Reddy's Laboratories Ltd | 12.21 USD | +0.25% | +0.16% | +2.01% | -14.01% | 10.19 B USD |